Top Markets
#1 DogBull DogBull +105.07%
#2 ADO Protocol ADO Protocol +63.44%
#3 Siacoin Siacoin +43.92%
#4 MarsCoin MarsCoin +39.02%
#5 UnifAI Network UnifAI Network +31.63%
#6 Useless Coin Useless Coin +30.98%
#7 Ontology Gas Ontology Gas +21.09%
#8 Magma Finance Magma Finance +19.84%
#9 Filecoin Filecoin +15.77%
#10 Falcon Finance Falcon Finance +14.73%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
AbClon Inc. AbClon Inc.

AbClon Inc.

174900
Rank in Stocks #15851
Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical... Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical company engaged in the discovery and development of antibody-based drugs, with operations spanning South Korea and Sweden. The firm's developmental pipeline encompasses therapies derived from distinct technological platforms: the NEST platform addresses breast and gastric cancers; the AffiMab platform targets colon cancer and various autoimmune conditions; and the CAR-T platform is engineered for hematologic and ovarian cancers.
Share Price
$16.42
Market Cap
$327.24M
Change (1 day)
-3.46%
Change (1 year)
129.62%
Country
KR
Trade AbClon Inc. (174900)

Category

Healthcare
P/E ratio for AbClon Inc. (174900)
P/E ratio as of 2026 TTM: 0
According to AbClon Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for AbClon Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 31.44 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 36.85 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -17.59 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 -23.32 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.